Shang (2020. május 29.). „Cell entry mechanisms of SARS-CoV-2”. Proceedings of the National Academy of Sciences117 (21), 11727–11734. o. DOI:10.1073/pnas.2003138117. PMID 32376634.
Starr (2021. április 1.). „Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016”. Cell Reports Medicine2 (4), 100255. o. DOI:10.1016/j.xcrm.2021.100255. PMID 33842902.
Di Giacomo (2021). „Preliminary report on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike mutation T478K”. Journal of Medical Virology. DOI:10.1002/jmv.27062. PMID 33951211.
South (2020. május 1.). „COVID-19, ACE2, and the cardiovascular consequences”. American Journal of Physiology-Heart and Circulatory Physiology318 (5), H1084–H1090. o. DOI:10.1152/ajpheart.00217.2020.
Zhang (2021. április 6.). „Emergence of a Novel SARS-CoV-2 Variant in Southern California”. JAMA325 (13), 1324–1326. o. DOI:10.1001/jama.2021.1612. PMID 33571356.
Hoffmann (2021. június 1.). „SARS-CoV-2 variant B.1.617 is resistant to Bamlanivimab and evades antibodies induced by infection and vaccination”. Cell Reports, 109415. o. DOI:10.1016/j.celrep.2021.109415. ISSN2211-1247. „Collectively, our study reveals that antibody evasion of B.1.617 may contribute to the rapid spread of this variant... ...The RBD of the B.1.617 S protein harbors two mutations associated with (L452R) or suspected (E484Q) of antibody evasion... ...Moreover, E484K present the B.1.351 and P.1 variants confers antibody resistance (Li et al., 2021) and one could speculate that exchange E484Q might have a similar effect.”
doi.org
Hoffmann (2021. június 1.). „SARS-CoV-2 variant B.1.617 is resistant to Bamlanivimab and evades antibodies induced by infection and vaccination”. Cell Reports, 109415. o. DOI:10.1016/j.celrep.2021.109415. ISSN2211-1247. „Collectively, our study reveals that antibody evasion of B.1.617 may contribute to the rapid spread of this variant... ...The RBD of the B.1.617 S protein harbors two mutations associated with (L452R) or suspected (E484Q) of antibody evasion... ...Moreover, E484K present the B.1.351 and P.1 variants confers antibody resistance (Li et al., 2021) and one could speculate that exchange E484Q might have a similar effect.”
Shang (2020. május 29.). „Cell entry mechanisms of SARS-CoV-2”. Proceedings of the National Academy of Sciences117 (21), 11727–11734. o. DOI:10.1073/pnas.2003138117. PMID 32376634.
Starr (2021. április 1.). „Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016”. Cell Reports Medicine2 (4), 100255. o. DOI:10.1016/j.xcrm.2021.100255. PMID 33842902.
Di Giacomo (2021). „Preliminary report on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike mutation T478K”. Journal of Medical Virology. DOI:10.1002/jmv.27062. PMID 33951211.
Zhang (2021. április 6.). „Emergence of a Novel SARS-CoV-2 Variant in Southern California”. JAMA325 (13), 1324–1326. o. DOI:10.1001/jama.2021.1612. PMID 33571356.
Koshy. „Coronavirus | Indian 'double mutant' strain named B.1.617”, The Hindu, 2021. április 8. (Hozzáférés: 2021. április 19.) (angol nyelvű) „Though these mutations have individually been found in several other coronavirus variants, the presence of both these mutations together have been first found in some coronavirus genomes from India.”
worldcat.org
Hoffmann (2021. június 1.). „SARS-CoV-2 variant B.1.617 is resistant to Bamlanivimab and evades antibodies induced by infection and vaccination”. Cell Reports, 109415. o. DOI:10.1016/j.celrep.2021.109415. ISSN2211-1247. „Collectively, our study reveals that antibody evasion of B.1.617 may contribute to the rapid spread of this variant... ...The RBD of the B.1.617 S protein harbors two mutations associated with (L452R) or suspected (E484Q) of antibody evasion... ...Moreover, E484K present the B.1.351 and P.1 variants confers antibody resistance (Li et al., 2021) and one could speculate that exchange E484Q might have a similar effect.”
